Royalty Pharma plc [RPRX] stock Downgrade by UBS analyst, price target now $28
Royalty Pharma plc [NASDAQ: RPRX] gained 0.61% or 0.19 points to close at $31.45 with a heavy trading volume of 3094835 shares. The daily chart for RPRX points out that the company has recorded 14.53% gains over the past six months. If we look at